HEADER IMMUNE SYSTEM 25-MAY-17 5XO2 TITLE CRYSTAL STRUCTURE OF HUMAN PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR TITLE 2 ALPHA WITH SYNTHESIZED GLYCOPEPTIDE II COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 32-150; COMPND 5 SYNONYM: CELL SURFACE RECEPTOR FDF03,INHIBITORY RECEPTOR PILR-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE FROM ENVELOPE GLYCOPROTEIN B; COMPND 9 CHAIN: X, Y; COMPND 10 SYNONYM: GB; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PILRA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 1; SOURCE 11 ORGANISM_COMMON: HHV-1; SOURCE 12 ORGANISM_TAXID: 10306 KEYWDS MEMBRANE PROTEIN, IMMUNE RECEPTOR, VIRAL ENTRY INHIBITOR, KEYWDS 2 GLYCOPEPTIDE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.FURUKAWA,K.KAKITA,T.YAMADA,M.ISHIZUKA,J.SAKAMOTO,N.HATORI,N.MAEDA, AUTHOR 2 F.OHSAKA,T.SAITOH,T.NOMURA,K.KUROKI,H.NAMBU,H.ARASE,S.MATSUNAGA, AUTHOR 3 M.ANADA,T.OSE,S.HASHIMOTO,K.MAENAKA REVDAT 4 22-NOV-23 5XO2 1 HETSYN LINK REVDAT 3 29-JUL-20 5XO2 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 24-JAN-18 5XO2 1 JRNL REVDAT 1 25-OCT-17 5XO2 0 JRNL AUTH A.FURUKAWA,K.KAKITA,T.YAMADA,M.ISHIZUKA,J.SAKAMOTO,N.HATORI, JRNL AUTH 2 N.MAEDA,F.OHSAKA,T.SAITOH,T.NOMURA,K.KUROKI,H.NAMBU,H.ARASE, JRNL AUTH 3 S.MATSUNAGA,M.ANADA,T.OSE,S.HASHIMOTO,K.MAENAKA JRNL TITL STRUCTURAL AND THERMODYNAMIC ANALYSES REVEAL CRITICAL JRNL TITL 2 FEATURES OF GLYCOPEPTIDE RECOGNITION BY THE HUMAN PILR ALPHA JRNL TITL 3 IMMUNE CELL RECEPTOR. JRNL REF J. BIOL. CHEM. V. 292 21128 2017 JRNL REFN ESSN 1083-351X JRNL PMID 29046357 JRNL DOI 10.1074/JBC.M117.799239 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13390 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 638 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2352 REMARK 3 BIN FREE R VALUE : 0.3188 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2058 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 49 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5XO2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ. REMARK 100 THE DEPOSITION ID IS D_1300003863. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13393 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3WV0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES MONOHYDRATE PH 6.5, 1.6M REMARK 280 MAGNESIUM SULFATE HEPTAHYDRATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 40.64000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.66450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 40.64000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.66450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, X, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, Y, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 121 -159.80 -165.81 REMARK 500 ALA B 62 -172.07 -69.18 REMARK 500 ARG B 85 104.38 -164.11 REMARK 500 GLU B 103 78.86 -54.87 REMARK 500 SER B 121 -159.61 -166.75 REMARK 500 SER B 134 14.69 -150.09 REMARK 500 REMARK 500 REMARK: NULL DBREF 5XO2 A 32 150 UNP Q9UKJ1 PILRA_HUMAN 32 150 DBREF 5XO2 B 32 150 UNP Q9UKJ1 PILRA_HUMAN 32 150 DBREF 5XO2 X 50 56 UNP P06437 GB_HHV1K 50 56 DBREF 5XO2 Y 50 56 UNP P06437 GB_HHV1K 50 56 SEQADV 5XO2 MET A 31 UNP Q9UKJ1 EXPRESSION TAG SEQADV 5XO2 GLY A 78 UNP Q9UKJ1 ARG 78 VARIANT SEQADV 5XO2 MET B 31 UNP Q9UKJ1 EXPRESSION TAG SEQADV 5XO2 GLY B 78 UNP Q9UKJ1 ARG 78 VARIANT SEQRES 1 A 120 MET LEU TYR GLY VAL THR GLN PRO LYS HIS LEU SER ALA SEQRES 2 A 120 SER MET GLY GLY SER VAL GLU ILE PRO PHE SER PHE TYR SEQRES 3 A 120 TYR PRO TRP GLU LEU ALA THR ALA PRO ASP VAL ARG ILE SEQRES 4 A 120 SER TRP ARG ARG GLY HIS PHE HIS GLY GLN SER PHE TYR SEQRES 5 A 120 SER THR ARG PRO PRO SER ILE HIS LYS ASP TYR VAL ASN SEQRES 6 A 120 ARG LEU PHE LEU ASN TRP THR GLU GLY GLN LYS SER GLY SEQRES 7 A 120 PHE LEU ARG ILE SER ASN LEU GLN LYS GLN ASP GLN SER SEQRES 8 A 120 VAL TYR PHE CYS ARG VAL GLU LEU ASP THR ARG SER SER SEQRES 9 A 120 GLY ARG GLN GLN TRP GLN SER ILE GLU GLY THR LYS LEU SEQRES 10 A 120 SER ILE THR SEQRES 1 B 120 MET LEU TYR GLY VAL THR GLN PRO LYS HIS LEU SER ALA SEQRES 2 B 120 SER MET GLY GLY SER VAL GLU ILE PRO PHE SER PHE TYR SEQRES 3 B 120 TYR PRO TRP GLU LEU ALA THR ALA PRO ASP VAL ARG ILE SEQRES 4 B 120 SER TRP ARG ARG GLY HIS PHE HIS GLY GLN SER PHE TYR SEQRES 5 B 120 SER THR ARG PRO PRO SER ILE HIS LYS ASP TYR VAL ASN SEQRES 6 B 120 ARG LEU PHE LEU ASN TRP THR GLU GLY GLN LYS SER GLY SEQRES 7 B 120 PHE LEU ARG ILE SER ASN LEU GLN LYS GLN ASP GLN SER SEQRES 8 B 120 VAL TYR PHE CYS ARG VAL GLU LEU ASP THR ARG SER SER SEQRES 9 B 120 GLY ARG GLN GLN TRP GLN SER ILE GLU GLY THR LYS LEU SEQRES 10 B 120 SER ILE THR SEQRES 1 X 7 GLY PRO ALA THR PRO ALA PRO SEQRES 1 Y 7 GLY PRO ALA THR PRO ALA PRO HET 8B9 C 1 13 HET SIA C 2 20 HET 8B9 D 1 13 HET SIA D 2 20 HETNAM 8B9 2-ACETAMIDO-2,4-DIDEOXY-ALPHA-D-XYLO-HEXOPYRANOSE HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETSYN 8B9 N-[(2S,3R,4S,6S)-6-(HYDROXYMETHYL)-2,4-BIS(OXIDANYL) HETSYN 2 8B9 OXAN-3-YL]ETHANAMIDE; 2-ACETAMIDO-2,4-DIDEOXY-ALPHA-D- HETSYN 3 8B9 XYLO-HEXOSE; 2-ACETAMIDO-2,4-DIDEOXY-D-XYLO-HEXOSE; 2- HETSYN 4 8B9 ACETAMIDO-2,4-DIDEOXY-XYLO-HEXOSE HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID FORMUL 5 8B9 2(C8 H15 N O5) FORMUL 5 SIA 2(C11 H19 N O9) FORMUL 7 HOH *49(H2 O) HELIX 1 AA1 LYS A 91 VAL A 94 5 4 HELIX 2 AA2 GLN A 116 GLN A 120 5 5 HELIX 3 AA3 LYS B 91 VAL B 94 5 4 HELIX 4 AA4 GLN B 116 GLN B 120 5 5 SHEET 1 AA1 4 GLY A 34 THR A 36 0 SHEET 2 AA1 4 VAL A 49 TYR A 56 -1 O SER A 54 N THR A 36 SHEET 3 AA1 4 SER A 107 ILE A 112 -1 O LEU A 110 N ILE A 51 SHEET 4 AA1 4 LEU A 97 ASN A 100 -1 N PHE A 98 O ARG A 111 SHEET 1 AA2 6 HIS A 40 SER A 44 0 SHEET 2 AA2 6 THR A 145 THR A 150 1 O LYS A 146 N LEU A 41 SHEET 3 AA2 6 SER A 121 ASP A 130 -1 N SER A 121 O LEU A 147 SHEET 4 AA2 6 ARG A 68 ARG A 73 -1 N SER A 70 O ARG A 126 SHEET 5 AA2 6 SER A 80 SER A 83 -1 O TYR A 82 N TRP A 71 SHEET 6 AA2 6 SER A 88 ILE A 89 -1 O SER A 88 N SER A 83 SHEET 1 AA3 4 HIS A 40 SER A 44 0 SHEET 2 AA3 4 THR A 145 THR A 150 1 O LYS A 146 N LEU A 41 SHEET 3 AA3 4 SER A 121 ASP A 130 -1 N SER A 121 O LEU A 147 SHEET 4 AA3 4 ARG A 136 GLN A 140 -1 O GLN A 137 N LEU A 129 SHEET 1 AA4 4 GLY B 34 THR B 36 0 SHEET 2 AA4 4 VAL B 49 TYR B 56 -1 O SER B 54 N THR B 36 SHEET 3 AA4 4 SER B 107 ILE B 112 -1 O LEU B 110 N ILE B 51 SHEET 4 AA4 4 LEU B 97 ASN B 100 -1 N ASN B 100 O PHE B 109 SHEET 1 AA5 6 HIS B 40 SER B 44 0 SHEET 2 AA5 6 THR B 145 THR B 150 1 O SER B 148 N LEU B 41 SHEET 3 AA5 6 SER B 121 ASP B 130 -1 N SER B 121 O LEU B 147 SHEET 4 AA5 6 ARG B 68 ARG B 73 -1 N SER B 70 O ARG B 126 SHEET 5 AA5 6 SER B 80 SER B 83 -1 O TYR B 82 N TRP B 71 SHEET 6 AA5 6 SER B 88 ILE B 89 -1 O SER B 88 N SER B 83 SHEET 1 AA6 4 HIS B 40 SER B 44 0 SHEET 2 AA6 4 THR B 145 THR B 150 1 O SER B 148 N LEU B 41 SHEET 3 AA6 4 SER B 121 ASP B 130 -1 N SER B 121 O LEU B 147 SHEET 4 AA6 4 ARG B 136 GLN B 140 -1 O TRP B 139 N VAL B 127 LINK OG1 THR X 53 C1 8B9 C 1 1555 1555 1.39 LINK OG1 THR Y 53 C1 8B9 D 1 1555 1555 1.39 LINK O6 8B9 C 1 C2 SIA C 2 1555 1555 1.38 LINK O6 8B9 D 1 C2 SIA D 2 1555 1555 1.38 CISPEP 1 ARG A 85 PRO A 86 0 -0.26 CISPEP 2 ARG B 85 PRO B 86 0 -0.30 CRYST1 81.280 63.329 55.072 90.00 110.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012303 0.000000 0.004497 0.00000 SCALE2 0.000000 0.015791 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019333 0.00000